The Characteristics of Patients Who Develop Long-COVID Symptoms
Researchers sought to examine the demographic and clinical characteristics of patients who developed long COVID.
Researchers sought to examine the demographic and clinical characteristics of patients who developed long COVID.
A lower risk for developing chemosensory loss was observed with alpha, delta, and omicron variants.
The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.
One in 9 patients hospitalized for COVID-19 died or were readmitted to the hospital within 30 days of their initial discharge.
A third shot can be given at least five months after healthy children complete the two-dose vaccine series.
Study characterized patient-reported delays in care of prostate cancer and bladder cancer at the national level.
Improvements were seen in physical and mental health, but survivors still had more symptoms than controls at two years.
Researchers assessed the frequency and severity of cognitive impairments over time and specifically 1 year after hospitalization in patients who contracted COVID-19.
Younger patients with cancer are “a high-risk population for poor outcomes from COVID-19,” according to researchers.
Persistent viral shedding was associated with an increased risk of in-hospital delirium and death at 6 months.